2020-2025 Global Pediatric Clinical Trials Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)

Clinical trials used by children to study and develop drugs or new drugs are called pediatric clinical trials. Most clinical trials are conducted in adults and very rare clinical trials, including children. To increase the level of participation of children in clinical trials, the United States has developed a regulatory and health strategy that focuses on the overall market for drugs when incorporated into pediatric clinical trials. According to the World Bank Group, approximately 26% of the world's population includes pediatrics (children between the ages of 0-14), rather than 10 times more clinical trials for adults than pediatrics. Because of the lack of pediatric clinical trials, ethical issues, and the infrastructure of pediatric diseases are relatively lower than those found in adults, pharmaceutical companies are paying more attention to drug development in adults.
This report elaborates the market size, market characteristics, and market growth of the Pediatric Clinical Trials industry, and breaks down according to the type, application, and consumption area of Pediatric Clinical Trials. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Pediatric Clinical Trials in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.
In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Pediatric Clinical Trials market covered in Chapter 13:
Covance Inc.
CenterWatch
Paidion Research, Inc.
Pharmaceutical Product Development LLC
Pfizer Inc
Parexel
Duke Clinical Research Institute
Quintiles

In Chapter 6, on the basis of types, the Pediatric Clinical Trials market from 2015 to 2025 is primarily split into:
Pre-Clinical
Phase I
Phase II
Phase III

In Chapter 7, on the basis of applications, the Pediatric Clinical Trials market from 2015 to 2025 covers:
Treatment Studies
Observational Studies

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:
United States
Europe
China
Japan
India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:
North America (Covered in Chapter 8)
United States
Canada
Mexico
Europe (Covered in Chapter 9)
Germany
UK
France
Italy
Spain
Others
Asia-Pacific (Covered in Chapter 10)
China
Japan
India
South Korea
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 11)
Saudi Arabia
UAE
South Africa
Others
South America (Covered in Chapter 12)
Brazil
Others

Years considered for this report:


Historical Years:

2015-2019

Base Year:

2019

Estimated Year:

2020

Forecast Period:

2020-2025

Frequently Asked Questions



This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports